Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
113.50    0.00 (0.00%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £15.31m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

AGM Statement

19 May 2016 07:00

RNS Number : 6672Y
Revolymer PLC
19 May 2016
 

19 May 2016

Revolymer plc ("Revolymer" or "the Company")

AGM Statement

At the Annual General Meeting of the Company being held today, Dr Bryan Dobson, Chairman of the Company will make the following comments:

"Trading in the first quarter of the current financial year is in line with our expectations, and we have continued to make good progress in gaining commercial traction with our product pipeline. In the Personal and Consumer Health Care market, our new line of natural hair styling polymers, RevCareTM Natural Effects, was well received at its product launch at the Paris InCosmetics trade show in April 2016. In the Home Care and Industrial market, RevCoatTM Bond, our novel polymeric adhesion promoter for high performance sealants and adhesives, is due for launch later in the second quarter of 2016. As announced on 25 January 2016, we have also secured a renewal and expansion of our contract to supply nicotine gum in Canada, as well as contracting with a new customer in Canada. 

This commercial progress follows on from our milestones in 2015, including two significant licence deals in our Home Care and Industrial business area (with Solvay and OCI). The Company is now positioned as a specialty chemicals business, focussed on controlled release, responsive systems and delivery systems that improve the functional performance of our customers' products in two high value business areas: Personal and Consumer Health Care and Home Care and Industrial, and we have aligned the organisation so that we are best placed to penetrate these markets.

Considering the remainder of 2016 and beyond, I look forward to continued commercial milestones being achieved in both our business areas, and management remains receptive to executing corporate transactions as a route to developing the business in parallel with its ongoing organic growth."

 

Ends

 

For further information please contact:

Revolymer plc

+44 (0) 1244 283 500

Kevin Matthews / Rob Cridland

 

 

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Adam James / Fabien Holler (Corporate Finance)

Charles Leigh-Pemberton (Corporate Broking)

 

 

About Revolymer

Revolymer is an AIM quoted company (registered number 08024489) whose vision is to be a specialty chemicals business focused on controlled release, responsive systems and delivery systems based on its expertise in the design and synthesis of polymers that improve the functional performance of its customers' products, thereby generating high margin business.

www.revolymer.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBCGDUUBBBGLI
Date   Source Headline
30th Mar 20217:00 amRNSFull Year Results Ended 31 December 2020
24th Mar 202111:06 amRNSSecond Price Monitoring Extn
24th Mar 202111:00 amRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSNotice of Final Results and Investor Presentation
23rd Mar 20212:06 pmRNSSecond Price Monitoring Extn
23rd Mar 20212:00 pmRNSPrice Monitoring Extension
23rd Mar 202111:05 amRNSSecond Price Monitoring Extn
23rd Mar 202111:00 amRNSPrice Monitoring Extension
28th Jan 20212:06 pmRNSSecond Price Monitoring Extn
28th Jan 20212:01 pmRNSPrice Monitoring Extension
27th Jan 202111:06 amRNSSecond Price Monitoring Extn
27th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 202111:05 amRNSSecond Price Monitoring Extn
26th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 20217:00 amRNSTrading Update for the year ended 31 December 2020
21st Jan 202111:05 amRNSSecond Price Monitoring Extn
21st Jan 202111:01 amRNSPrice Monitoring Extension
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn
18th Jan 20212:01 pmRNSPrice Monitoring Extension
14th Jan 20214:41 pmRNSSecond Price Monitoring Extn
14th Jan 20214:35 pmRNSPrice Monitoring Extension
14th Jan 20212:06 pmRNSSecond Price Monitoring Extn
14th Jan 20212:01 pmRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSAppointment of new Vice President, Operations
8th Jan 202111:06 amRNSSecond Price Monitoring Extn
8th Jan 202111:00 amRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
3rd Nov 20207:00 amRNSAppointment of New Marketing and Sales Executive
28th Oct 20207:00 amRNSHalf Year Results
23rd Oct 20202:30 pmRNSResult of AGM
21st Oct 20207:00 amRNSNotice of Interim Results
13th Oct 202011:06 amRNSSecond Price Monitoring Extn
13th Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20204:35 pmRNSPrice Monitoring Extension
2nd Oct 20203:17 pmRNSCorrection to Full Year Results
30th Sep 20207:00 amRNSFull Year Results
16th Sep 20208:00 amRNSHolding(s) in Company
15th Sep 20207:00 amRNSNotice of Results
22nd Jul 20207:14 amRNSH1 2020 Trading Update
17th Jul 20201:36 pmRNSHolding(s) in Company
17th Jul 202011:18 amRNSHolding(s) in Company
15th Jul 20203:04 pmRNSDirector/PDMR Shareholding
14th Jul 202012:51 pmRNSResult of General Meeting
26th Jun 20206:01 pmRNSNotice of GM and Posting of Circular
24th Jun 20203:33 pmRNSResult of Fundraise
24th Jun 20207:55 amRNSClose of Accelerated Bookbuild
23rd Jun 20205:31 pmRNSLaunch of Fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.